Pacira BioSciences News

Pacira BioSciences Analyst Ratings

BenzingaAug 13 10:01 ET

Truist Financial Downgrades Pacira BioSciences(PCRX.US) to Sell Rating, Announces Target Price $8

Moomoo NewsAug 13 06:31 ET

Truist Securities Downgrades Pacira BioSciences to Sell From Buy, Adjusts Price Target to $8 From $30

MT NewswiresAug 13 06:25 ET

Barclays Maintains Pacira BioSciences(PCRX.US) With Hold Rating, Maintains Target Price $25

Moomoo NewsAug 13 05:33 ET

Pacira Pharmaceuticals (PCRX) Gets a Hold From Barclays

TipRanksAug 13 04:51 ET

Pacira Downgraded by J.P. Morgan, Piper, RBC, Raymond James

Seeking AlphaAug 12 15:29 ET

Piper Sandler Downgrades Pacira BioSciences to Neutral From Overweight, Adjusts Price Target to $11 From $42

MT NewswiresAug 12 06:57 ET

Pacira BioSciences Analyst Ratings

BenzingaAug 12 06:27 ET

Barclays Maintains Pacira BioSciences(PCRX.US) With Hold Rating, Maintains Target Price $25

Moomoo NewsAug 5 04:33 ET

Pacira BioSciences Price Target Cut to $37.00/Share From $42.00 by RBC Capital

Dow JonesJul 31 10:32 ET

Raymond James Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Cuts Target Price to $37

Moomoo NewsJul 31 09:48 ET

A Quick Look at Today's Ratings for Pacira BioSciences(PCRX.US), With a Forecast Between $37 to $43

Moomoo NewsJul 31 09:19 ET

RBC Lowers Price Target on Pacira BioSciences to $37 From $42, Keeps Outperform Rating

MT NewswiresJul 31 08:08 ET

Pacira BioSciences Analyst Ratings

BenzingaJul 31 05:44 ET

Barclays Issues a Hold Rating on Pacira Pharmaceuticals (PCRX)

TipRanksJul 30 03:57 ET

Pacira BioSciences Analyst Ratings

BenzingaJul 25 11:04 ET

Truist Cuts Price Target on Pacira BioSciences to $30 From $45, Keeps Buy Rating

MT NewswiresJul 25 08:01 ET

Truist Financial Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Announces Target Price $30

Moomoo NewsJul 25 07:31 ET

Barclays Downgrades Pacira BioSciences to Equalweight From Overweight, Adjusts Price Target to $25 From $38

MT NewswiresJul 3 05:45 ET

Pacira BioSciences Analyst Ratings

BenzingaJul 2 13:24 ET